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RESULTS

BACKGROUND

●Infants born to parents with opioid use

disorders (OUDs) are at higher risk for
developmental delays and future educational
and behavioral problems
●These infants frequently qualify for Early
Intervention (EI) child development services
●EI is a possible source of support at a critical
time for parents with OUDs
●There are few targeted approaches to
supporting families in recovery through child
home-visiting services

OBJECTIVE
To explore barriers and facilitators to integrating a
targeted parenting intervention for families
affected by OUDs into child home-visiting services
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●Inclusion criteria: Parents in recovery from

OUDs with children under 10 years of age in
Western Massachusetts and providers of
addiction child development health or social
services
●Semi-structured qualitative interviews and focus
groups were conducted (N=38)
●Each interview or focus group was transcribed,
coded, and analyzed using a qualitative
descriptive approach
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●13 parents and 25 providers
●Provider occupations included EI providers, an
EI director, a DPH program coordinator,
hospital staff, DCF, social workers, recovery
program staff, and mental health providers
●Focus groups took place in Greenfield,
Northampton, and Springfield, MA
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CONCLUSIONS

●The presentation and marketing is critical for

initial engagement of parents with OUDs
●Methods require future training for EI providers
on recovery
●Beginning parenting programs prior to the birth
of the child may encourage parent enrollment
●Peer sharing (recovery coach) involvement in
some capacity may also be beneficial to parents
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Collaborative Care for Kids: A Resident Driven School Nurse Education Initiative
Kelsey Kaman MD¹ and Jhill Shah DO¹, Taylor Koerner MD¹, Chandrika Sridharamurthy MD¹
¹University of Massachusetts Medical School-Baystate
BACKGROUND:
• In 2018 Springfield was named the worst city in the
county to live with asthma
• We met with community stakeholders and realized
that collaborating with school nurses would be a
great way to help alleviate the burden of asthma in
the pediatric population
• During initial meetings, school nurses made us aware
that there are many other conditions that they would
like more guidance on managing and overcoming
barriers to care
• According to the AAP in “Role of the School Nurse in
Providing School Health Services”, school nurses are
critical in management of ADHD, diabetes, lifethreatening allergies, asthma, seizures and behavioral
health concerns
• We also recognized that when school nurses are not
confident in their skills, they are more likely to send
children perhaps inappropriately home or to
Emergency Departments resulting in lost time at
school for the kids and lost time at work for the
parents. By addressing this issue, we hope to be
helping every school aged child in Springfield to
optimize their health and educational opportunities
• Our aim: Residents to teach 5 courses throughout the
year about recognizing and caring for common
complaints and urgent situations that could arise in
the school setting related to asthma, anaphylaxis, etc.

OBJECTIVE:

DESIGN:

CONCLUSIONS:

• Enhance nursing medical knowledge of
common pediatric complaints and
management in the school setting

• 5 classes over the course of one academic school
year held during regularly scheduled professional
development classes

• Foster open, easy, reliable, and efficient
communication between school nurses
and local pediatricians

• Address 5 areas: Asthma, Allergies, Skin Rashes,
Neuro: Seizures and Concussions, and Abdominal
Complains

• Link school nurses with community
resources including non-profit
organizations as well as local pediatricians
that are accepting new patients

• Pre-test and post-test at each session

RESULTS:

• Incentives for participation include coffee
breakfast s, gift cards, and end of the year raffles

Figure 1: Pre and Post-Testing scores for Asthma Class
For asthma session, the average pre-test score was 66.1%.
The post-test scored an average of 74.5%.

Figure 1: Pre-test and Post-test Results
76

• Our first session was asthma and was a very successful event
that every school nurse in Springfield attended
• We learned about common misconceptions school nurses have
about asthma and were able to address many of them
• Importantly, we also learned things we as community
pediatricians can do to help nurses manage asthma better in the
outpatient setting such as yearly asthma action plans, labels for
inhalers, encouraging kids with asthma (and their families) to
continue to walk to school, play outside during recess and
participate in gym

Figure 2: On a scale from 1-5, how comfortable are you
contacting a student’s pediatrician to talk about his/her asthma?
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Multifactorial Renal Injury in a Pancreatic Cancer Patient
Crystal Cobb DO, Angela Slick MD, Deirdre Lewis MD
University of Massachusetts Medical School-Baystate
Department of Internal Medicine-Pediatrics

DISCUSSION CONTINUED

LEARNING OBJECTIVES

● This patient’s underlying pancreatic cancer and chemotherapy
likely caused IgA nephropathy.

1. Review mechanisms for renal injury in cancer patients
2. Evaluate a unique case of IgA nephropathy and explore the
possible pathophysiologic mechanisms

● IgA nephropathy is thought to be a result of genetic and
environmental factors in a "multi-hit" model of renal injury.1

CASE PRESENTATION
A 66 y/o female with a past medical history significant for
pancreatic cancer on gemcitabine and paclitaxel presented to the
ED with fever, nausea, vomiting, and tachycardia in the setting of
recent initiation of chemotherapy. She was initially started on
broad spectrum antibiotics for possible sepsis however these
were discontinued as it became more apparent that her
presenting symptoms were likely side effects of chemotherapy.
On hospital day #5 patient’s course become complicated by
marked increase in creatinine from 0.8mg/dL to 3.2 mg/dL and
worsening thrombocytopenia. Her creatinine peaked at 4.6 mg/dL.
An ultrasound guided needle kidney biopsy was performed.
Biopsy results were significant for acute tubular injury with likely
underlying IgA nephropathy. Patient’s creatinine nomalized with
IV fluids.

DISCUSSION
● Nephrotoxicity is a common complication of treatment in
patients with malignancy, however may be underestimated due
to subclinical presentation or lack of standardized
surveillance.2
● This is illustrated in this case as the patient’s renal injury was
unexpected and likely multifactorial.
● Initially there was concern for thrombotic microangiopathy, a
well known complication of gemcitabine therapy, given her
rapidly rising creatinine and precipitously falling platelets.3
Biopsy did not show TMA, however did reveal acute tubular
injury (ATN) and IgA nephropathy.

● IgA nephropathy may be primary or secondary. Secondary IgA
nephropathy can be caused by a variety of systemic illnesses
including neoplastic disorders and is thought to be due to
increased IgA production, production of abnormal IgA or
impaired clearance.
Figure 1: Renal Biopsy. Glomerular tuft with hypercellularity
cons is tent with IGAN and confirmed by light micros copy4
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Figure 2: Patient’s lab data. Illus trates patient’s s teep ris e in
creatinine with falling platelet count and the s tart of
s ubs equent recovery

● There have been case reports of association with malignancy
and chemotherapy that posit mucosal injury secondary to
metastatic disease itself, chemotherapies, radiation and surgery
lead to glomerular IgA immune complex deposition.
● Other confounders in this case include acute tubular injury
secondary to contrast induced ATN from a CT scan done as part
of her workup, possibly augmented by dehydration from the
side effects of chemotherapy.

CONCLUSION
Malignancy and chemotherapy can both cause renal injury such
as IgA nephropathy. Thus, it is important to remain vigilant about
monitoring for potential effects of malignancy and antineoplastic
drugs. Increased monitoring of renal function may be indicated in
patients with malignancy in order to better understand and
prevent renal injury.
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